DL

David Longo

Chief Executive Officer

Ordaos Bio

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ordaos Bio
Industry
research
Employees
30.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
10574704.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 Microsoft Azure Monitor Atlassian Cloud Netlify Hubspot Mobile Friendly Facebook Widget Linkedin Login Facebook Login (Connect) Linkedin Widget Android Circle SharePoint Remote Python AI

Keywords

pharmaceuticals & artificial intelligence biotechnology research mini-proteins drugs generative ai biologics protein design drug discovery customized proteins targeted therapies ai-driven drug design pharmaceutical partnerships therapeutic candidates disease microenvironments binding affinity immunogenicity multitask meta-learning reinforcement learning in silico design therapeutic solutions drug-like properties protein stability manufacturing efficiency biotech collaborations clinical success rate pharma innovation therapeutic optimization high throughput screening cutting-edge research drug development speed optimized binding novel therapies safety in treatments peptide profiles minimized aggregation disease-focused r&d sustainable manufacturing ai application in biotech proprietary algorithms innovative therapeutics biopharma advancements single domain antibodies epitope binding continuous learning loop high-quality data generation functional assays quality control in r&d

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans